Cargando…

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice

Background. Multidisciplinary team (MDT) working in oncology aims to improve outcomes for patients with cancer. One role is to ensure the implementation of best practice and National Institute for Health and Clinical Excellence (NICE) guidance. In this study, we have assessed the role of MDT in impl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, Stephen J., Whittle, Ian R., Ashkan, Keyoumars, Grundy, Paul, Cruickshank, Garth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432583/ https://www.ncbi.nlm.nih.gov/pubmed/22482926 http://dx.doi.org/10.3109/02688697.2012.673651

Ejemplares similares

Adverse Event with the Use of Carmustine Wafers and Postoperative Radiochemotherapy for the Treatment of High-grade Glioma
por: Salle, Federico, et al.
Publicado: (2018)

Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
por: Chowdhary, Sajeel A., et al.
Publicado: (2015)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016)

Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide
por: Kleinberg, Lawrence
Publicado: (2012)

In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography
por: Doishita, Satoshi, et al.
Publicado: (2017)

Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy
por: Kleinberg, Lawrence
Publicado: (2016)

Early Postoperative Expansion of Parenchymal High-intensity Areas on T(2)-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma
por: MASUDA, Yosuke, et al.
Publicado: (2015)

Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
por: Manini, Ivana, et al.
Publicado: (2022)

Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers
por: Brem, Steven, et al.
Publicado: (2013)

Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report
por: Kuramitsu, Shunichiro, et al.
Publicado: (2014)

Symptomatic cerebral vasospasm in the setting of carmustine wafer placement for glioblastoma: A case presentation and review of literature
por: Khan, Maheen Qamar, et al.
Publicado: (2020)

MPC-03 IMMUNOHISTOCHEMICAL ANALYSIS OF TUMOR ASSOCIATED MACROPHAGE INDUCED AFTER BIODEGRADABLE CARMUSTINE WAFER IMPLANTATION IN HUMAN GLIOBLASTOMA
por: Shibahara, Ichiyo, et al.
Publicado: (2019)

Multicellular “hotspots” harbor high-grade potential in lower-grade gliomas
por: Kirby, Alastair J, et al.
Publicado: (2021)

Glioblastoma fed by middle meningeal artery and displaying cyst formation soon after repeated implantation of carmustine wafers: A case report
por: Yamamuro, Shun, et al.
Publicado: (2017)

NICE medical technologies guidance: aims for clinical practice
por: Campbell, Bruce
Publicado: (2013)

Recent NICE guidance of interest to surgeons
por: Campbell, Bruce
Publicado: (2013)

Examining the implementation of NICE guidance: cross-sectional survey of the use of NICE interventional procedures guidance by NHS Trusts
por: Lowson, Karin, et al.
Publicado: (2015)

Chronic Phase Intracranial Hemorrhage Caused by Ruptured Pseudoaneurysm Induced by Carmustine Wafer Implantation for Insulo-opercular Anaplastic Astrocytoma: A Case Report
por: SATO, Kimitoshi, et al.
Publicado: (2015)

Is Interstitial Chemotherapy with Carmustine (BCNU) Wafers Effective against Local Recurrence of Glioblastoma? A Pharmacokinetic Study by Measurement of BCNU in the Tumor Resection Cavity
por: Ohnishi, Takanori, et al.
Publicado: (2022)

NICE family history guidance and implementation update
por: Mackay, J
Publicado: (2006)

Management of rheumatoid arthritis: summary of NICE guidance
por: Deighton, Chris, et al.
Publicado: (2009)

Trends in procedures for infertility and caesarean sections: was NICE disinvestment guidance implemented? NICE recommendation reminders
por: Chamberlain, Charlotte A, et al.
Publicado: (2013)

The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS
por: Vink, Mark, et al.
Publicado: (2022)

Carmustine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
por: Jilani, Kashif, et al.
Publicado: (2013)

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
por: Bock, Hans Christoph, et al.
Publicado: (2010)

The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine
por: Karbownik, Michał Seweryn, et al.
Publicado: (2014)

Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells
por: Sukumari-Ramesh, Sangeetha, et al.
Publicado: (2015)

When to suspect child maltreatment: summary of NICE guidance
por: Saperia, Julia, et al.
Publicado: (2009)

Gastro-oesophageal reflux disease in children: NICE guidance
por: Davies, Ieuan, et al.
Publicado: (2015)

Diagnosis and treatment of advanced breast cancer: summary of NICE guidance
por: Murray, N, et al.
Publicado: (2009)

Management of generalised anxiety disorder in adults: summary of NICE guidance
por: Kendall, Tim, et al.
Publicado: (2011)

NICE guidance for moderate RA—a step in the right direction
por: The Lancet Rheumatology
Publicado: (2021)

Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report
por: Watts, Colin, et al.
Publicado: (2023)

Is National Institute of Clinical Excellence (NICE) guideline a nice guideline?
por: Agarwal, Ashok, et al.
Publicado: (2017)

Nice
por: Kunkler, Ian
Publicado: (1999)

NICE Cancer Guidance: a description of the Institute's Clinical Guideline Programme
por: Littlejohns, P, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_sdmj92h9l9sscshopvs1vibkmq